Project description
Tumour–lymph node-on-chip platform for personalised cancer treatment
The lymphatic system is an integral part of the adaptive immune system, and in many cases, tumours use lymphatic vessels to spread and colonise downstream lymph nodes (LNs). The EU-funded Tumor-LN-oC project is funding a solution for a robust, automated tumour–lymph node-on-chip platform able to connect primary tumours and LN tissue obtained from the same cancer patient. The project will use advances in the fields of microfluidics, cell biology, cancer biology, physics and computer programming to study the interaction of primary tumours with LNs and offer personalised treatment based on molecular characterisation of metastasising cells.
Fields of science
- natural sciencesphysical sciencesclassical mechanicsfluid mechanicsmicrofluidics
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsignal processing
- medical and health sciencesbasic medicineimmunology
- medical and health sciencesclinical medicineoncology
- natural sciencescomputer and information sciencesartificial intelligencemachine learningdeep learning
Programme(s)
Funding Scheme
RIA-LS - Research and Innovation action Lump SumCoordinator
10682 Athina
Greece
See on map
Participants (10)
5612 AE Eindhoven
See on map
115 27 Athina
See on map
20500 Abo
See on map
2072 Saint-blaise
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
RG21 8EN Basingstoke
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1040 Wien
See on map
75011 Paris
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
15341 Agia Paraskevi Athina
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
08014 Barcelona
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
160 00 Praha 6
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.